financetom
Business
financetom
/
Business
/
Rubrik Narrows Fiscal Q3 Loss as Revenue Rises, Issues Guidance -- Shares Surge After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rubrik Narrows Fiscal Q3 Loss as Revenue Rises, Issues Guidance -- Shares Surge After Hours
Dec 5, 2024 1:50 PM

04:34 PM EST, 12/05/2024 (MT Newswires) -- Rubrik ( RBRK ) was surging over 15% in extended trading Thursday after reporting a fiscal Q3 non-GAAP net loss of $0.21 per diluted share, narrower than $1.39 loss a year ago.

Analysts polled by FactSet, on average, expected a $0.40 loss.

Total revenue for the quarter that ended Oct. 31 was $236.2 million compared with $165.6 million a year earlier.

Analysts expected $217.5 million.

For fiscal Q4, the firm is projecting a non-GAAP loss of $0.41 to $0.37 on revenue of $231.5 million to $233.5 million. Analysts are expecting a $0.41 loss and $224.5 million, respectively.

For full year, the firm is projecting a non-GAAP loss of $1.86 to $1.82 on revenue of $860 million to $862 million. Analysts are expecting a $2.09 loss and $834.1 million, respectively.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Onex Buys Back 3.1% of Shares for $264.2 Million in Substantial Issuer Bid
Onex Buys Back 3.1% of Shares for $264.2 Million in Substantial Issuer Bid
Dec 27, 2024
07:55 AM EST, 12/27/2024 (MT Newswires) -- Onex ( ONEXF ) said Friday that it bought back 3.1% of its shares for $264.2 million in a substantial issuer bid that expired on Monday. The company repurchased for cancellation 2.3 million outstanding subordinate voting shares at $117.00 apiece. The bid had authorized the company to repurchase for cancellation up to $400...
BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties
BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties
Dec 27, 2024
Dec 27 (Reuters) - BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennyslvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings on Friday. The German company, which partners with U.S. pharma giant Pfizer ( PFE ) for its COVID-19 vaccine, said it...
BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties
BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties
Dec 27, 2024
(Reuters) - BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennyslvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings on Friday. The German company, which partners with U.S. pharma giant Pfizer for its COVID-19 vaccine, said it would pay $791.5 million to...
Inno Holdings Files $150 Million Mixed Securities Shelf
Inno Holdings Files $150 Million Mixed Securities Shelf
Dec 27, 2024
07:52 AM EST, 12/27/2024 (MT Newswires) -- Inno Holdings ( INHD ) filed a registration statement Thursday for the potential sale of up to $150 million of its securities from time to time. The filing covers the sale of the company's common stock, debt securities, warrants, rights and units, Inno Holdings ( INHD ) said. The company said it aims...
Copyright 2023-2026 - www.financetom.com All Rights Reserved